Peter Bentham
0000-0002-6443-3353
5 papers found
Refreshing results…
A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer’s disease and agitated behaviours: the HTA-SYMBAD trial
Degeneration of basal and limbic networks is a core feature of behavioural variant frontotemporal dementia
Assistive technology and telecare to maintain independent living at home for people with dementia: the ATTILA RCT
Minocycline 200 mg or 400 mg versus placebo for mild Alzheimer’s disease: the MADE Phase II, three-arm RCT
Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT
Missing publications? Search for publications with a matching author name.